Poster zum Thema "Cell Biology Insights"

Zurück
  • P-III-0917
In-depth phosphoproteomic profiling of the insulin signaling response in heart tissue and cardiomyocytes unveils canonical and specialized regulation
  • Jonathan Achter (Copenhagen / DK)
  • Estefania Torres Vega (Copenhagen / DK)
  • P-III-0918
Kinome-profiling using patient-derived cell lines to discover novel therapeutic targets for treating dermatofibrosarcoma protuberans with resistance to imatinib
  • P-III-0919
Neprilysin protease substrates: degradomics reveals novel roles in mitochondria and in neurodegeneration
  • P-III-0921
SureQuant-based absolute quantification of the Lysosomal mouse proteome
  • P-III-0922
Developing a model to assess the impact of dysregulated protein methyltransferase domains using EHMT2 in colorectal cancer
  • P-III-0923
Matrix stiffness regulates the protein profile of extracellular vesicles of pancreatic cancer cell lines
  • P-III-0924
Diving into the hidden world of AltProts: unraveling functions and interactions
  • P-III-0925
Large-scale proteomics as a tool to disclose molecular mechanisms of the phenolic compound gibbilimbol B
  • P-III-0926
The inadequate expression of LCRMP-1 leads to sinoatrial dysfunction through disrupting calcium cycling
  • P-III-0927
Characterisation of the MSS-CRC surface proteome for novel immunotherapeutic target discovery
  • P-III-0929
In-depth proteomic profiling of eosinophils and neutrophils to unveil molecular insights into immune system function
  • P-III-0930
Comprehensive proteomic profiling of converted Adipocyte-like cells from normal human dermal fibroblast using Data-Independent Acquisition Mass Spectrometry (DIA-MS)
  • P-III-0931
Mechanical response proteomics of cancer cells
  • P-III-0932
Targeted proteomics reveals the regulation of the polycomb repressive complex 1 by USP7 and its involvement in neurodevelopment
  • P-III-0933
Comprehensive proteomics landscape of human myeloid antigen-presenting cells
  • P-III-0934
GPX1 expression promotes stemness and aggressiveness in sarcomas
  • P-III-0935
Enhancing high-grade serous ovarian cancer treatment through proteomic and phosphoproteomic analysis
  • P-III-0936
Characterizing surfacome and secretome dynamics upon cellular perturbation
  • P-III-0937
High-throughput profiling of PROTAC-induced protein degradation using mePROD quantitative proteomics
  • P-III-0938
The study of fundamental biological determinants of the plasma proteome using proteographTM rise and murine models
  • P-III-0940
High throughput affinity pull-down interactomics
  • P-III-0941
Spatiotemporal dissection of protein localization to human primary cilia
  • P-III-0942
Mapping of the synaptic mitochondrial interactome by crosslinking mass spectrometry (XL-MS)
  • P-III-0943
Reducing ribosome biogenesis upregulates interferon-stimulated gene translation
  • P-III-0944
Unravelling the role of reactive oxygen species in glucose-stimulated insulin secretion: insights from oxidative and phosphoproteomic analysis
  • P-III-0945
A comprehensive study of the effect of IDH1 mutation in glioblastoma multiforme progression combining proteome, transcriptome and clinical data
  • P-III-0946
Exploring the role of dynamic protein profiling in bone Marrow-Derived mesenchymal stem cells and their influence on metastatic behavior in non-Malignant non-small cell lung cancer cells
  • P-III-0947
Using high-throughput expression and spatial proteomics to characterise remodelling of HEK293 cells during the production of recombinant adeno-associated virus (rAAV)-8
  • P-III-0948
Intra- and extracellular proteome dynamics during normal and malignant hematopoietic stem cell expansion
  • P-III-0949
Understanding telomere-driven genomic instability through proximity labelling proteomics
  • P-III-0950
Deep proteomic characterization of more than 120 cell lines
  • P-III-0951
The essential roles of checkpoint kinase 1 in DNA damage checkpoint response
  • P-III-0952
Pharmacoproteomic profiling identifies secreted markers for aberrant drug action
  • P-III-0953
RNF213 plays a role in NRF2 signaling by regulating the DNA damage response
  • P-III-0954
Acetylsalicylic acid effects on malignant melanocyte cellular proteome, secretome and extracellular vesicle proteome
  • P-III-0955
Protein turnover during PINK1/Parkin-dependent Mitophagy measured by dynamic SILAC
  • P-III-0956
Towards deciphering the evolutionary process of endosymbiont – organelle transition of chromatophores in Paulinella chromatophora by MS-based spatial proteomics (LOPIT-DC)
  • P-III-0957
Investigating protein and organelle degradation selectivity by autophagy using targeted proteomics
  • P-III-0958
Secretome analysis deciphers microglia-derived inflammatory signals and identifies an inducer of neuronal deficit
  • P-III-0959
Testing the robustness of a BONCAT strategy for detection of rapamycin-induced small changes in protein translation after short-term treatment of HEK293 cells
  • P-III-0960
Quantitative proteomic analysis of Carboplatin resistance in 2D and 3D cultured high-grade serous ovarian cancer cells
  • P-III-0961
Proteome signatures of the aging retina reveal sexual dimorphism in mice with targeted Ephx2 gene knockout
  • P-III-0962
Identification of drug target engagement of repurposing candidates for polycystic kidney disease by thermal proteome profiling
  • P-III-0963
Relative quantification of (phospho)proteoforms reveals important common disease pathways in Retinitis pigmentosa mouse models
  • P-III-0964
Exploring the molecular factors governing the unconventional protein secretory pathway using quantitative proteomics
  • P-III-0965
Interplay between photosynthetic electron flux and organic carbon sinks in sucrose-excreting Synechocystis sp. PCC6803 revealed by omics approaches
  • P-III-0966
Mass spectrometry-based proteomics to explore intratumoral heterogeneity in PAX3::FOXO1 fusion positive rhabdomyosarcoma
  • P-III-0967
Proteomic and biochemical investigation of the effects of ERAP1 functional disruption in melanoma cells
  • P-III-0968
Systematic identification of degrader drug targets by deep proteomic screening and high-sensitivity ubiquitinomics
  • P-III-0969
Elucidating protease substrate specificities with enhanced secretome profiling techniques
  • P-III-0971
Analysis of keratin post-translational modifications during cell division
  • P-III-0972
The specificity of macrophage's proteome: a comparison with HeLa cell line
  • P-III-0973
Large clostridial toxins reorganize the proteome and phosphoproteome of target cells
  • P-III-0974
Mapping heterogeneity in the protein landscape of human sperm
  • P-III-0975
Characterization of breast cancer tumoroids subclones by proteomics for personalize medicine
  • P-III-0976
Hypoxia and Hyperglycemia-induced proteomic changes in retinal pigment epithelial cells: implications for tight junctions and vascular integrity
  • P-III-0977
Proteomics reveals key differences in neutrophils activation by PMA and Ionomycin
  • P-III-0978
Investigating Dynamic Cellular Crosstalk and Pathomechanisms in Experimental Peritoneal Dialysis through Secretomics Analysis
  • P-III-0979
Highlighting the fate of brain pericytes under the blood-brain barrier-associated conditions and neuropathological contexts by mass spectrometry approaches
  • P-III-0980
Proteomic evidence of the inhibition in astrocytes of Heimdall, an alternative protein related to a variable light chain kappa, switches astrocytes to a neural stem cell phenotype
  • P-III-0981
Cross-Linking Mass Spectrometry to Capture Protein Network Dynamics of Cell Membranome
  • P-III-0982
Identifying novel engineering targets from evolved host populations using proteomics
  • P-III-0983
High fat diet promotes increased protein expression of MTPF1 and enhanced mitochondrial fission in fast type IIa skeletal muscle fibers
  • P-III-0984
Characterizing global translation and mitochondrial protein import in senescence using mePROD and mePRODmt
  • P-III-0985
Mapping the proteomic landscape of healthy human brains over the aging process
  • P-III-0986
Integrative study of patient-derived in-vitro model toward pharmaco-proteogenomics
  • P-III-0987
Dietary influence on protein post-translational modifications: insights on protein acetylation and malonylation
  • P-III-0988
Kingdom of reproductive life; core sperm proteome
  • P-III-0989
Relative quantification of membrane associated EGFR from human cancer cell lines via a SILAC based method
  • P-III-0990
Proteomic strategy to identify the cell-surface progesterone-receptor mediating nongenomic steroid-signaling in human sperm cells
  • P-III-0991
Intestinal organoids – a potential screening tool for advanced drug delivery systems
  • P-III-0992
Insight into communication mechanisms in MLL-rearranged Leukemia
  • P-III-0993
Proteomic and high-resolution microscopy analysis of the role of Dysferlin in membrane remodelling after myocardial infarction
  • P-III-0994
Multilayered omics reveal sex- and depot-dependent adipose progenitor cell heterogeneity
  • P-III-0996
Investigating the regulatory role of Palmitoylation during cell divisions
  • P-III-0997
Proteomic analysis of PACS2 syndrome in a murine model: insights into molecular pathways and calcium regulation
    • v1.20.0
    • © Conventus Congressmanagement & Marketing GmbH